cbdMD Inc (NYSE MKT:YCBD) — Market Cap & Net Worth
Market Cap & Net Worth: cbdMD Inc (YCBD)
cbdMD Inc (NYSE MKT:YCBD) has a market capitalization of $6.58 Million ($6.58 Million) as of September 23, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #28132 globally and #5781 in its home market, demonstrating a -6.08% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying cbdMD Inc's stock price $0.76 by its total outstanding shares 8912959 (8.91 Million). Also see YCBD total assets for a full breakdown of the balance sheet.
cbdMD Inc Market Cap History: 2017 to 2026
cbdMD Inc's market capitalization history from 2017 to 2026. Data shows change from $1.74 Billion to $6.78 Million (-49.36% CAGR). Also see YCBD cash flow metrics for how efficiently the company converts equity into cash flow.
cbdMD Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how cbdMD Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check cbdMD Inc stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.17x
cbdMD Inc's market cap is 0.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.74 Billion | $4.47 Million | -$1.74 Million | 389.88x | N/A |
| 2018 | $1.24 Billion | $8.42 Million | -$412.07K | 147.19x | N/A |
| 2019 | $906.45 Million | $23.65 Million | -$45.43 Million | 38.33x | N/A |
| 2020 | $1.18 Billion | $41.88 Million | $12.60 Million | 28.25x | 93.89x |
| 2021 | $433.17 Million | $44.48 Million | -$23.39 Million | 9.74x | N/A |
| 2022 | $91.05 Million | $35.40 Million | -$74.09 Million | 2.57x | N/A |
| 2023 | $9.27 Million | $24.16 Million | -$22.94 Million | 0.38x | N/A |
| 2024 | $3.34 Million | $19.48 Million | -$3.70 Million | 0.17x | N/A |
Competitor Companies of YCBD by Market Capitalization
Companies near cbdMD Inc in the global market cap rankings as of September 23, 2026. Review cbdMD Inc tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to cbdMD Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #651 globally with a market cap of $42.68 Billion USD ( CN¥291.65 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #524 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #586 | GALDERMA GROUP AG | NYSE:GALDY | $46.44 Billion | $39.83 |
| #638 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.50 |
| #651 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $42.68 Billion | CN¥45.72 |
cbdMD Inc Historical Marketcap From 2017 to 2026
Between 2017 and today, cbdMD Inc's market cap moved from $1.74 Billion to $ 6.78 Million, with a yearly change of -49.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $6.78 Million | -43.63% |
| 2025 | $12.03 Million | +260.00% |
| 2024 | $3.34 Million | -63.94% |
| 2023 | $9.27 Million | -89.82% |
| 2022 | $91.05 Million | -78.98% |
| 2021 | $433.17 Million | -63.39% |
| 2020 | $1.18 Billion | +30.53% |
| 2019 | $906.45 Million | -26.86% |
| 2018 | $1.24 Billion | -28.97% |
| 2017 | $1.74 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of cbdMD Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.58 Million USD |
| MoneyControl | $6.58 Million USD |
| MarketWatch | $6.58 Million USD |
| marketcap.company | $6.58 Million USD |
| Reuters | $6.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About cbdMD Inc
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated p… Read more